Clinical Trials Browser

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Endometrial Hyperplasia, Ovarian Neoplasms, Endometrial Neoplasms

NCT03010124 2026-03-20

OvBIOMark

Phase NA Recruiting

350 enrolled

Gynecologic

Ovarian Neoplasms

NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Suspended

22 enrolled

BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

NCT06572735 2026-02-23

PARIB-OLD-PRO²

Recruiting

50 enrolled

Gynecologic

Neoplasms, Ovarian Neoplasms

NCT06071286 2026-02-11

SPEED

Phase NA Recruiting

30 enrolled

Gynecologic

Ovarian Neoplasms

NCT04794322 2025-09-16

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Recruiting

250 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Ovarian Diseases, Ovarian Neoplasms

NCT03958240 2025-09-15

DECIDE

Phase NA Recruiting

1,100 enrolled

GastrointestinalGynecologicHead & NeckThoracic

Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Ovarian Neoplasms

NCT03776630 2025-08-12

GYNO-MIR

Phase NA Active not recruiting

363 enrolled

Gynecologic

Disease, Ovarian Neoplasms, Endometrial Neoplasms

NCT01953159 2025-06-08

Assessment of Paclitaxel-Induced Neuropathy

Active not recruiting

43 enrolled

BreastGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms

NCT02662621 2025-06-05

EXODIAG

Phase NA Completed

71 enrolled

BreastGynecologicThoracic

Breast Neoplasms, Disease, Lung Neoplasms, Neoplasms, Ovarian Neoplasms

Clinical Trials

ECHO

OvBIOMark

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

PARIB-OLD-PRO²

SPEED

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

DECIDE

GYNO-MIR

Assessment of Paclitaxel-Induced Neuropathy

EXODIAG